Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Elagolix did not effectively treat polycystic ovary syndrome.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Abatacept may help some people with alopecia areata regrow hair.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Korean psoriasis patients still use alternative medicine despite effective biologics.